These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1615705)

  • 1. The effects of cobalt chloride, SKF-525A, and N-(3,5-dichlorophenyl)succinimide on in vivo hepatic mixed function oxidase activity as determined by single-sample plasma clearances.
    Bachmann KA; Madhira MS; Rankin GO
    Xenobiotica; 1992 Jan; 22(1):27-31. PubMed ID: 1615705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of single-sample clearance estimates to probe hepatic drug metabolism in rats. IV. A model for possible application to phenotyping xenobiotic influences on human drug metabolism.
    Bachmann KA
    Xenobiotica; 1989 Dec; 19(12):1449-59. PubMed ID: 2618092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism.
    Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB
    Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
    Bachmann KA; Yang C; Jahn D; Schwartz J
    Xenobiotica; 1988 Feb; 18(2):151-9. PubMed ID: 3131969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status in vivo.
    Bachmann KA; Jauregui L
    Xenobiotica; 1993 Mar; 23(3):307-15. PubMed ID: 8498093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise training does not alter cytochrome P-450 content and microsomal metabolism.
    Michaud TJ; Bachmann KA; Andres FF; Flynn MG; Sherman GP; Rodriguez-Zayas J
    Med Sci Sports Exerc; 1994 Aug; 26(8):978-82. PubMed ID: 7968432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cimetidine or ranitidine pretreatment on hepatic mixed function oxidase activity in the rat.
    Yee NS; Shargel L
    Drug Metab Dispos; 1986; 14(5):580-4. PubMed ID: 2876865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of phenobarbitone on human hepatic drug metabolism.
    Bachmann KA; Nunlee M; Martin M; Jaregui L
    Xenobiotica; 1991 Oct; 21(10):1385-92. PubMed ID: 1796615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal induction of haem oxygenase without concurrent degradation of cytochrome P-450. Protective effects of compound SKF 525A on the haem protein.
    Drummond GS; Rosenberg DW; Kappas A
    Biochem J; 1982 Jan; 202(1):59-66. PubMed ID: 6896277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
    Spaethe SM; Jollow DJ
    Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity of N-(3,5-dichlorophenyl)succinimide metabolites in vivo and in vitro.
    Rankin GO; Shih HC; Yang DJ; Richmond CD; Teets VJ; Brown PI
    Toxicol Appl Pharmacol; 1988 Dec; 96(3):405-16. PubMed ID: 3206523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of three probes to assess the influence of sex on hepatic drug metabolism.
    Bachmann KA; Schwartz J; Jauregui L; Sullivan TJ; Martin M
    Pharmacology; 1987; 35(2):88-93. PubMed ID: 3628465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. II.
    Bachmann KA; Jahn D; Yang C; Schwartz J
    Xenobiotica; 1988 Feb; 18(2):161-7. PubMed ID: 3131970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in tissue distribution of chlordecone (kepone) in the rat following phenobarbital or SKF-525A administration.
    Aldous CN; Chetty CS; Desaiah D
    J Toxicol Environ Health; 1983 Mar; 11(3):365-72. PubMed ID: 6188850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of SKF-525A and of altered hepatic blood flow on lidocaine clearance in the cat.
    Lautt WW; Skelton FS
    Can J Physiol Pharmacol; 1977 Feb; 55(1):7-12. PubMed ID: 843992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
    Chindavijak B; Belpaire FM; Bogaert MG
    Pharmacology; 1988; 36(4):279-82. PubMed ID: 3380881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SKF-525A on liver metabolism and hepatotoxicity of tri- and dibutyltin compounds in mice.
    Ueno S; Suzuki T; Susa N; Furukawa Y; Sugiyama M
    Arch Toxicol; 1997; 71(8):513-8. PubMed ID: 9248630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons.
    Pelkonen O; Sotaniemi EA; Ahokas JT
    Br J Clin Pharmacol; 1985 Jan; 19(1):59-66. PubMed ID: 3978021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of cholestyramine treatment on hepatic mixed function oxidase activity.
    Bachmann K; Schwartz J; Forney R; Sherman G; Jauregui L
    Pharmacology; 1984; 29(3):128-41. PubMed ID: 6483959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.